Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Franz Diffusion Cell Approach for Pre-Formulation Characterisation of Ketoprofen Semi-Solid Dosage Forms.

Salamanca CH, Barrera-Ocampo A, Lasso JC, Camacho N, Yarce CJ.

Pharmaceutics. 2018 Sep 5;10(3). pii: E148. doi: 10.3390/pharmaceutics10030148.

2.

Natural gum-type biopolymers as potential modified nonpolar drug release systems.

Salamanca CH, Yarce CJ, Moreno RA, Prieto V, Recalde J.

Carbohydr Polym. 2018 Jun 1;189:31-38. doi: 10.1016/j.carbpol.2018.02.011. Epub 2018 Feb 8.

PMID:
29580414
3.

Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex.

Salamanca CH, Yarce CJ, Roman Y, Davalos AF, Rivera GR.

Pharmaceuticals (Basel). 2018 Feb 10;11(1). pii: E19. doi: 10.3390/ph11010019.

4.

Relationship between the Polymeric Ionization Degree and Powder and Surface Properties in Materials Derived from Poly(maleic anhydride-alt-octadecene).

Salamanca CH, Yarce CJ, Zapata CA, Giraldo JA.

Molecules. 2018 Feb 2;23(2). pii: E320. doi: 10.3390/molecules23020320.

5.

Influence of transmucosal height in abutments of single and multiple implant-supported prostheses: a non-linear three-dimensional finite element analysis.

Borie E, Leal E, Orsi IA, Salamanca C, Dias FJ, Weber B.

Comput Methods Biomech Biomed Engin. 2018 Jan;21(1):91-97. doi: 10.1080/10255842.2018.1425405. Epub 2018 Jan 10.

PMID:
29318899
6.

Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?

Cochrane DR, Tessier-Cloutier B, Lawrence KM, Nazeran T, Karnezis AN, Salamanca C, Cheng AS, McAlpine JN, Hoang LN, Gilks CB, Huntsman DG.

J Pathol. 2017 Sep;243(1):26-36. doi: 10.1002/path.4934. Epub 2017 Aug 7.

PMID:
28678427
7.

Relationship between Surface Properties and In Vitro Drug Release from Compressed Matrix Containing Polymeric Materials with Different Hydrophobicity Degrees.

Yarce CJ, Echeverri JD, Palacio MA, Rivera CA, Salamanca CH.

Pharmaceuticals (Basel). 2017 Jan 24;10(1). pii: E15. doi: 10.3390/ph10010015.

8.

Physicochemical characterization of in situ drug-polymer nanocomplex formed between zwitterionic drug and ionomeric material in aqueous solution.

Salamanca CH, Castillo DF, Villada JD, Rivera GR.

Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:405-414. doi: 10.1016/j.msec.2016.11.097. Epub 2016 Nov 26.

PMID:
28024603
9.

Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.

Fernández ML, DiMattia GE, Dawson A, Bamford S, Anderson S, Hennessy BT, Anglesio MS, Shepherd TG, Salamanca C, Hoenisch J, Tinker A, Huntsman DG, Carey MS.

Am J Cancer Res. 2016 Oct 1;6(10):2235-2251. eCollection 2016.

10.

Extraction of espresso coffee by using gradient of temperature. Effect on physicochemical and sensorial characteristics of espresso.

Salamanca CA, Fiol N, González C, Saez M, Villaescusa I.

Food Chem. 2017 Jan 1;214:622-630. doi: 10.1016/j.foodchem.2016.07.120. Epub 2016 Jul 21.

PMID:
27507518
11.

Relationship between Surface Properties and In Vitro Drug Release from a Compressed Matrix Containing an Amphiphilic Polymer Material.

Yarce CJ, Pineda D, Correa CE, Salamanca CH.

Pharmaceuticals (Basel). 2016 Jun 24;9(3). pii: E34. doi: 10.3390/ph9030034.

12.

Assessment of buccal bone thickness of aesthetic maxillary region: a cone-beam computed tomography study.

Fuentes R, Flores T, Navarro P, Salamanca C, Beltrán V, Borie E.

J Periodontal Implant Sci. 2015 Oct;45(5):162-8. doi: 10.5051/jpis.2015.45.5.162. Epub 2015 Oct 26.

13.

Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville.

de Felipe B, Olbrich P, Lucenas JM, Delgado-Pecellin C, Pavon-Delgado A, Marquez J, Salamanca C, Soler-Palacin P, Gonzalez-Granado LI, Antolin LF, Borte S, Neth O.

Pediatr Allergy Immunol. 2016 Feb;27(1):70-7. doi: 10.1111/pai.12501. Epub 2015 Nov 23.

PMID:
26498110
14.

Description of intraoral pressures on sub-palatal space in young adult patients with normal occlusion.

Fuentes R, Engelke W, Flores T, Navarro P, Borie E, Curiqueo A, Salamanca C.

Int J Clin Exp Med. 2015 Jul 15;8(7):11208-13. eCollection 2015.

15.

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research.

Anglesio MS, Wiegand KC, Melnyk N, Chow C, Salamanca C, Prentice LM, Senz J, Yang W, Spillman MA, Cochrane DR, Shumansky K, Shah SP, Kalloger SE, Huntsman DG.

PLoS One. 2013 Sep 27;8(9). doi: 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a. eCollection 2013.

16.

Type-specific cell line models for type-specific ovarian cancer research.

Anglesio MS, Wiegand KC, Melnyk N, Chow C, Salamanca C, Prentice LM, Senz J, Yang W, Spillman MA, Cochrane DR, Shumansky K, Shah SP, Kalloger SE, Huntsman DG.

PLoS One. 2013 Sep 4;8(9):e72162. doi: 10.1371/journal.pone.0072162. eCollection 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/856f0890-9d85-4719-8e54-c27530ac94f4. PLoS One. 2013;8(9). doi:10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a.

17.

Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.

Anglesio MS, Wang Y, Yang W, Senz J, Wan A, Heravi-Moussavi A, Salamanca C, Maines-Bandiera S, Huntsman DG, Morin GB.

J Pathol. 2013 Feb;229(3):400-9. doi: 10.1002/path.4135.

PMID:
23132766
18.

BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells.

Karve TM, Preet A, Sneed R, Salamanca C, Li X, Xu J, Kumar D, Rosen EM, Saha T.

PLoS One. 2012;7(6):e37697. doi: 10.1371/journal.pone.0037697. Epub 2012 Jun 1.

19.

Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.

Heravi-Moussavi A, Anglesio MS, Cheng SW, Senz J, Yang W, Prentice L, Fejes AP, Chow C, Tone A, Kalloger SE, Hamel N, Roth A, Ha G, Wan AN, Maines-Bandiera S, Salamanca C, Pasini B, Clarke BA, Lee AF, Lee CH, Zhao C, Young RH, Aparicio SA, Sorensen PH, Woo MM, Boyd N, Jones SJ, Hirst M, Marra MA, Gilks B, Shah SP, Foulkes WD, Morin GB, Huntsman DG.

N Engl J Med. 2012 Jan 19;366(3):234-42. doi: 10.1056/NEJMoa1102903. Epub 2011 Dec 21.

20.

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.

Schrader KA, Masciari S, Boyd N, Salamanca C, Senz J, Saunders DN, Yorida E, Maines-Bandiera S, Kaurah P, Tung N, Robson ME, Ryan PD, Olopade OI, Domchek SM, Ford J, Isaacs C, Brown P, Balmana J, Razzak AR, Miron P, Coffey K, Terry MB, John EM, Andrulis IL, Knight JA, O'Malley FP, Daly M, Bender P; kConFab, Moore R, Southey MC, Hopper JL, Garber JE, Huntsman DG.

J Med Genet. 2011 Jan;48(1):64-8. doi: 10.1136/jmg.2010.079814. Epub 2010 Oct 4.

21.

The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.

Schrader KA, Gorbatcheva B, Senz J, Heravi-Moussavi A, Melnyk N, Salamanca C, Maines-Bandiera S, Cooke SL, Leung P, Brenton JD, Gilks CB, Monahan J, Huntsman DG.

PLoS One. 2009 Nov 24;4(11):e7988. doi: 10.1371/journal.pone.0007988.

22.

Iced vs room-temperature injectates for cardiac index measurement during hypothermia and normothermia.

Walsh E, Adams S, Chernipeski J, Cloud J, Gillies E, Fox R, Luckeroth P, Rice M, Salamanca C, Sherman B, Nezworski A, Ash T.

Am J Crit Care. 2010 Jul;19(4):365-72. doi: 10.4037/ajcc2009255. Epub 2009 Aug 17.

23.

SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells.

Woo MM, Salamanca CM, Symowicz J, Stack MS, Miller DM, Leung PC, Gilks CB, Auersperg N.

Gynecol Oncol. 2008 Oct;111(1):125-31. doi: 10.1016/j.ygyno.2008.06.021. Epub 2008 Aug 3.

PMID:
18678400
24.

The eukaryotic translation elongation factor eEF1A2 induces neoplastic properties and mediates tumorigenic effects of ZNF217 in precursor cells of human ovarian carcinomas.

Sun Y, Wong N, Guan Y, Salamanca CM, Cheng JC, Lee JM, Gray JW, Auersperg N.

Int J Cancer. 2008 Oct 15;123(8):1761-9. doi: 10.1002/ijc.23708.

25.

Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas.

Woo MM, Salamanca CM, Miller M, Symowicz J, Leung PC, Oliveira C, Ehlen TG, Gilks CB, Huntsman D, Auersperg N.

Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1234-47. doi: 10.1111/j.1525-1438.2007.01171.x. Epub 2008 Jan 23.

PMID:
18217967
26.

An improved assay to quantitate the invasiveness of cells in modified Boyden chambers.

Woo MM, Salamanca CM, Minor A, Auersperg N.

In Vitro Cell Dev Biol Anim. 2007 Jan;43(1):7-9.

PMID:
17570027
27.

Partial molar volume of anionic polyelectrolytes in aqueous solution.

Salamanca C, Contreras M, Gamboa C.

J Colloid Interface Sci. 2007 May 15;309(2):435-9. Epub 2007 Mar 12.

PMID:
17350646
28.

Caspase-1alpha is down-regulated in human ovarian cancer cells and the overexpression of caspase-1alpha induces apoptosis.

Feng Q, Li P, Salamanca C, Huntsman D, Leung PC, Auersperg N.

Cancer Res. 2005 Oct 1;65(19):8591-6.

29.

Effects of epidermal growth factor/hydrocortisone on the growth and differentiation of human ovarian surface epithelium.

Salamanca CM, Maines-Bandiera SL, Leung PC, Hu YL, Auersperg N.

J Soc Gynecol Investig. 2004 May;11(4):241-51.

PMID:
15120699
30.

alphavbeta3 and vitronectin expression by normal ovarian surface epithelial cells: role in cell adhesion and cell proliferation.

Cruet S, Salamanca C, Mitchell GW, Auersperg N.

Gynecol Oncol. 1999 Nov;75(2):254-60.

PMID:
10525382
31.

Supplemental Content

Loading ...
Support Center